Teladoc Health Inc (0LDR.L)

Name: Teladoc Health Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Equipment Services

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$642M

Net Income

-$25.1M

Operating Margin

-5.6%

Free Cash Flow

$285M

Debt / Assets

55.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Teladoc Health Inc (0LDR.L).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	642,269,000	626,439,000	631,900,000	629,369,000
Cost of Revenue	197,048,000	187,179,000	190,537,000	196,829,000
Gross Profit	445,221,000	439,260,000	441,363,000	432,540,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	208,126,000	221,873,000	325,612,000	329,652,000
Operating Expenses	481,218,000	491,222,000	495,748,000	553,151,000
Operating Income	-35,997,000	-51,962,000	-54,385,000	-120,611,000
Interest Expense	4,950,000	4,526,000	4,473,000	5,765,000
Income Before Tax	-33,618,000	-50,222,000	-40,423,000	-111,267,000
Income Tax Expense	-8,475,000	-715,000	-7,763,000	-18,255,000
Net Income	-25,143,000	-49,507,000	-32,660,000	-93,012,000
Per Share
EPS	-0.14	-0.28	-0.19	-0.53
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Teladoc Health Inc (0LDR.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	2,529,977,000	2,569,574,000	2,602,415,000	2,406,840,000
Cost of Revenue	771,593,000	751,270,000	760,031,000	1,000,014,000
Gross Profit	1,758,384,000	1,818,304,000	1,842,384,000	1,406,826,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,085,263,000	1,346,270,000	1,367,293,000	1,300,563,000
Operating Expenses	2,021,339,000	2,839,190,000	2,090,937,000	1,634,192,000
Operating Income	-262,955,000	-1,020,886,000	-248,553,000	-227,366,000
Interest Expense	19,714,000	23,803,000	22,282,000	9,270,000
Income Before Tax	-235,530,000	-993,653,000	-219,608,000	-13,663,343,000
Income Tax Expense	-35,208,000	7,592,000	760,000	-3,812,000
Net Income	-200,322,000	-1,001,245,000	-220,368,000	-13,659,531,000
Per Share
EPS	-1.14	-5.87	-1.36	-84.60
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Teladoc Health Inc (0LDR.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	781,084,000	1,298,327,000	1,123,675,000	918,182,000
Short Term Investments	0	0	0	0
Net Receivables	201,660,000	223,955,000	230,063,000	235,645,000
Inventory	38,203,000	38,138,000	29,513,000	56,342,000
Total Current Assets	1,087,309,000	1,663,907,000	1,489,048,000	1,285,432,000
Property Plant Equipment	53,091,000	56,579,000	72,092,000	71,472,000
Goodwill and Intangibles	1,580,277,000	1,714,550,000	2,750,971,000	2,909,955,000
Total Assets	3,100,797,000	3,516,524,000	4,392,369,000	4,700,955,000
Liabilities
Account Payables	47,967,000	33,130,000	43,637,000	47,690,000
Short Term Debt	11,037,000	561,060,000	10,752,000	13,592,000
Total Current Liabilities	404,738,000	941,535,000	420,616,000	399,769,000
Long Term Debt	1,029,128,999	1,023,553,000	1,581,525,000	1,535,288,000
Total Liabilities	1,715,091,000	2,025,445,000	2,066,296,000	2,393,210,000
Shareholders Equity
Retained Earnings	-16,430,222,000	-16,229,900,000	-15,228,655,000	-15,008,287,000
Total Shareholders Equity	1,385,706,000	1,491,079,000	2,326,073,000	2,307,745,000

Balance sheet annual history for Teladoc Health Inc (0LDR.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	781,084,000	1,298,327,000	1,123,675,000	918,182,000
Short Term Investments	0	0	0	0
Net Receivables	201,660,000	223,955,000	230,063,000	235,645,000
Inventory	38,203,000	38,138,000	29,513,000	56,342,000
Total Current Assets	1,087,309,000	1,663,907,000	1,489,048,000	1,285,432,000
Property Plant Equipment	53,091,000	56,579,000	72,092,000	71,472,000
Goodwill and Intangibles	1,580,277,000	1,714,550,000	2,750,971,000	2,909,955,000
Total Assets	3,100,797,000	3,516,524,000	4,392,369,000	4,700,955,000
Liabilities
Account Payables	47,967,000	33,130,000	43,637,000	47,690,000
Short Term Debt	11,037,000	561,060,000	10,752,000	13,592,000
Total Current Liabilities	404,738,000	941,535,000	420,616,000	399,769,000
Long Term Debt	1,029,128,999	1,023,553,000	1,581,525,000	1,535,288,000
Total Liabilities	1,715,091,000	2,025,445,000	2,066,296,000	2,393,210,000
Shareholders Equity
Retained Earnings	-16,430,222,000	-16,229,900,000	-15,228,655,000	-15,008,287,000
Total Shareholders Equity	1,385,706,000	1,491,079,000	2,326,073,000	2,307,745,000

Cash flow quarterly history for Teladoc Health Inc (0LDR.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-200,322,000	-1,001,245,000	-220,368,000	-13,659,531,000
Depreciation & Amortization	363,120,000	382,843,000	351,323,000	270,643,000
Stock Based Compensation	80,414,000	145,951,000	201,550,000	217,852,000
Change in Working Capital	1,075,000	-36,315,000	11,643,000	-60,971,000
Operating Cash Flow	294,357,000	293,680,000	350,021,000	189,292,000
Investing Activities
Capital Expenditure	-8,893,000	-10,790,000	-156,348,000	-172,764,000
Investments	-8,893,000	-10,790,000	-156,348,000	-172,764,000
Investing Cash Flow	-266,003,000	-124,052,000	-156,347,000	-167,743,000
Financing Activities
Debt Repayment	-550,629,000	0	0	-3,147,000
Common Stock Issued/Repurchased	3,085,000	8,314,000	10,854,000	12,385,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-551,652,000	8,312,000	10,854,000	6,497,000
Summary
Free Cash Flow	285,464,000	282,890,000	193,673,000	16,528,000
Net Change in Cash	-517,243,000	174,652,000	205,493,000	24,702,000

Cash flow annual history for Teladoc Health Inc (0LDR.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-200,322,000	-1,001,245,000	-220,368,000	-13,659,531,000
Depreciation & Amortization	363,120,000	382,843,000	351,323,000	270,643,000
Stock Based Compensation	80,414,000	145,951,000	201,550,000	217,852,000
Change in Working Capital	1,075,000	-36,315,000	11,643,000	-60,971,000
Operating Cash Flow	294,357,000	293,680,000	350,021,000	189,292,000
Investing Activities
Capital Expenditure	-8,893,000	-10,790,000	-156,348,000	-172,764,000
Investments	-8,893,000	-10,790,000	-156,348,000	-172,764,000
Investing Cash Flow	-266,003,000	-124,052,000	-156,347,000	-167,743,000
Financing Activities
Debt Repayment	-550,629,000	0	0	-3,147,000
Common Stock Issued/Repurchased	3,085,000	8,314,000	10,854,000	12,385,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-551,652,000	8,312,000	10,854,000	6,497,000
Summary
Free Cash Flow	285,464,000	282,890,000	193,673,000	16,528,000
Net Change in Cash	-517,243,000	174,652,000	205,493,000	24,702,000